2m 2m 2m 2m 2m 2m 2m
PYXIS ONCOLOGY (PYXS)
NASDAQ
$2.31-$0.13 (-5.53%)
Price as of Jul 14, 2026 12:39 PM EDT- $154.6MMarket Cap
- 105.04%1-Year Change
- BiotechnologyIndustry
PYXIS ONCOLOGY (PYXS)
$2.31-$0.13 (-5.53%)
PYXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.44 | ||
Change | -$0.23 (-8.61%) | ||
Open | $2.65 | ||
High | $2.68 | ||
Low | $2.42 | ||
Previous Close | $2.67 | ||
Volume | 942,978 | ||
30-Day Average Volume | 1,506,043 | ||
1-Week Change | -0.81% | ||
1-Month Change | 38.64% | ||
1-Year Change | 105.04% | ||
3-Year Change | -12.23% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 63.4M | ||
Total Assets | $64.3M | ||
Market Cap | $154.6M | ||
Enterprise Value | $148.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$23.3M | ||
Free Cash Flow | -$26.0M | ||
EBIT | -$23.3M | ||
EBITDA | -$22.8M | ||
Net Working Capital | $29.0M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue